Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraosseous MSCs for Primary Graft Failure
NCT03389919Phase 3Unknown
- Sponsor
- National Medical Research Center for Hematology
- Start
- Jan 2017
- Primary completion
- Dec 2020
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 3 trial of Provacel in Graft failure, sponsored by National Medical Research Center for Hematology. Status: unknown.
02
Drugs
Provacel
03
Conditions
Graft failure
Beyond the preview
Go deeper on NCT03389919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03389919.